Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Presents Paper on Potential of Deep Data on Immune Complex Stability to ... Evaxion BiotechApril 20, 2021 GMT COPENHAGEN, Denmark, April 20, 2021 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (Nasdaq: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of patients with cancer, bacterial diseases and viral infections, announced today a presentation by Jens Kringelum, PhD, Evaxion...